TY - JOUR
T1 - Urinary PGE-M
T2 - A promising cancer biomarker
AU - Wang, Dingzhi
AU - DuBois, Raymond N.
PY - 2013/6
Y1 - 2013/6
N2 - Cancer prevention, early diagnosis, and targeted therapies are the keys to success in better cancer control and treatment. A big challenge remains to identify biomarkers for predicting who may have higher cancer risk and are able to respond to certain chemopreventive agents as well as for assessing a patient's response during treatment. Although a large body of evidence indicates that chronic inflammation is a risk factor for cancer, it is unclear whether inflammatory biomarkers can be used to predict cancer risk, progression, and death. Considering the importance of the proinflammatory COX-2-derived prostaglandin E2 (PGE2) in inflammation and cancer, Morris and colleagues found that urinary PGE-M is positively associated with obesity, smoking, and lung metastases in patients with breast cancer (4). Along the same lines, Kim and colleagues showed a potential association between urinary PGE-M and breast cancer risk in postmenopausal women (beginning on page 511). In agreement with previous reports, their findings indicate that urinary PGE-M may serve as a promising biomarker for prognosticating cancer risk and disease progression.
AB - Cancer prevention, early diagnosis, and targeted therapies are the keys to success in better cancer control and treatment. A big challenge remains to identify biomarkers for predicting who may have higher cancer risk and are able to respond to certain chemopreventive agents as well as for assessing a patient's response during treatment. Although a large body of evidence indicates that chronic inflammation is a risk factor for cancer, it is unclear whether inflammatory biomarkers can be used to predict cancer risk, progression, and death. Considering the importance of the proinflammatory COX-2-derived prostaglandin E2 (PGE2) in inflammation and cancer, Morris and colleagues found that urinary PGE-M is positively associated with obesity, smoking, and lung metastases in patients with breast cancer (4). Along the same lines, Kim and colleagues showed a potential association between urinary PGE-M and breast cancer risk in postmenopausal women (beginning on page 511). In agreement with previous reports, their findings indicate that urinary PGE-M may serve as a promising biomarker for prognosticating cancer risk and disease progression.
UR - http://www.scopus.com/inward/record.url?scp=84878857014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878857014&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-13-0153
DO - 10.1158/1940-6207.CAPR-13-0153
M3 - Comment/debate
C2 - 23636051
AN - SCOPUS:84878857014
SN - 1940-6207
VL - 6
SP - 507
EP - 510
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 6
ER -